Perspectives: Pros, Cons Of Vaccine Rollout Plans; Time To Make Science Bipartisan Again

Opinion writers weigh in on these pandemic issues and others.

To Roll Out Covid-19 Vaccines, Vaccinate Everyone In Several Hot Zones

Dear CEOs of Pfizer, Moderna, and AstraZeneca,
Thank you for rapidly mobilizing your scientific resources and your vaccine clinical trial networks. (We also thank Operation Warp Speed and others for organizing and underwriting your efforts to tame Covid-19.) Your vaccines are on the brink of crossing the finish line of approval, but the confusion surrounding the presidential transition has brought great uncertainty to the distribution plan. (Daniel Teres and Martin Strosberg, 12/3)

Read More

3 Ex-Presidents Say They Will Take Coronavirus Vaccine On Camera : Coronavirus Updates : NPR

Presidents Barack Obama, George W. Bush and Bill Clinton volunteered to take the coronavirus vaccine, once it’s available, on camera to assuage concerns about the shot.

Icon Sportswire via Getty Images

hide caption

toggle caption

Icon Sportswire via Getty Images

Presidents Barack Obama, George W. Bush and Bill Clinton volunteered to take the coronavirus vaccine, once it’s available, on camera to assuage concerns about the shot.

Icon Sportswire via Getty Images

Who better to promote a product than a former president? How about three?

Former Presidents Barack Obama, George W. Bush and Bill Clinton are willing to lend their star power for a good cause, saying this week that they would publicly take a coronavirus vaccine, once it’s available in the U.S., to encourage skeptical Americans to do the same.

Obama said that if Dr. Anthony Fauci, the country’s top infectious disease expert, thought the vaccine was safe and effective,

Read More

Obama, Bush And Clinton Will Get On-Camera Covid-19 Vaccine To Boost Public Confidence As Trump Remains Silent


Former Presidents Barack Obama, George W. Bush and Bill Clinton have each volunteered to receive their Covid-19 vaccine in public and on-camera in a bid to boost shaky public confidence in the vaccines’ safety, which has been undermined by their speedy development and months of politicization on both sides of the aisle. 

Key Facts

The three most recent former presidents have said they want to do their part to address the significant problem of vaccine hesitancy in the U.S., and encourage the public to go out and get vaccinated against Covid-19 when the Food and Drug Administration has authorized one, which it is expected to do so in the coming days and weeks.

Obama told SiriusXM’s Joe Madison

Read More

Hackers Are Targeting the Covid-19 Vaccine ‘Cold Chain’

Since the Covid-19 pandemic began, hackers and scammers have focused extraordinary attention on it, whether for espionage or for grift. Now, as pharmaceutical companies prepare to ship long-awaited vaccines, a new round of sophisticated phishing attacks is focused on the complex supply chain that will get them to people in need.

Two of the leading Covid-19 vaccine candidates, by Pfizer and Moderna, have been submitted to the FDA for emergency authorization; the agency is scheduled to evaluate Pfizer’s application on December 10, and Moderna’s one week later. UK regulators approved Pfizer’s vaccine on Wednesday. Which means that the next challenge for both vaccines is transporting them. They must be kept at frigid temperatures—minus 4 degrees Fahrenheit for Moderna, and 94 degrees below for Pfizer—requiring a network of specialists known as the “cold chain.” Today, security researchers at IBM are releasing findings that a campaign has for months targeted a significant

Read More

Former US presidents Obama, Clinton, and Bush say they are willing to take their COVID-19 shots on camera to show the vaccine is safe

a man holding a baseball bat: Former President Barack Obama. Kevin Lamarque/Reuters

© Kevin Lamarque/Reuters
Former President Barack Obama. Kevin Lamarque/Reuters

  • Former US presidents Barack Obama, George W. Bush, and Bill Clinton said they are willing to film their COVID-19 vaccinations to build public confidence in the shot’s safety and effectiveness.
  • Obama said in an interview scheduled Thursday: “I may end up taking it on TV or having it filmed, just so that people know that I trust this science, and what I don’t trust is getting COVID.”
  • Clinton’s press secretary told CNN he will take it publicly “if it will help urge all Americans to do the same.”
  • Bush has contacted Dr. Anthony Fauci and Dr. Deborah Birx, two of the US’ leading physicians, to see how he can encourage American to get vaccinated, his chief of staff said.
  • Their comments come after polls suggest many Americans are wary about getting the COVID-19 vaccine. 
  • Visit Business Insider’s homepage for more stories.
Read More

Coronavirus Vaccine Makers Targeted By North Korean Hackers Who Wanted To Steal Information


  • Kimsuky hacker group targeted at least six drugmakers
  • The cyberattacks targeted companies developing COVID-19 treatment
  • Russian and North Korean hackers attacked AstraZeneca in November

A group of North Korean hackers has targeted half a dozen pharmaceutical companies in the United States, United Kingdom and South Korea in a coordinated cyberattack. 

Kimsuky, a notorious hacker group, targeted drugmakers working on potential coronavirus vaccines and treatments as part of an effort to steal sensitive information that could be sold or weaponized by the North Korean regime. 

Authorities said any stolen information could be used to extort victims or give foreign governments a strategic advantage. 

Since August, the hackers have worked to infiltrate U.S. companies Johnson & Johnson and Novavax Inc. The hackers also launched coordinated cyberattacks on South Korean companies Genexine Inc., Shin Poong Pharmaceutical Co. and Celltrion Inc., sources told the Wall Street Journal.

Both American drugmakers are working

Read More

Pfizer coronavirus vaccine approved for emergency use in UK: ‘Help is on the way’ | Health care/Hospitals

British officials authorized a COVID-19 vaccine for emergency use on Wednesday, greenlighting the world’s first shot against the virus that’s backed by rigorous science and taking a major step toward eventually ending the pandemic.

The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany’s BioNTech comes as the coronavirus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

The Medicines and Healthcare Products Regulatory Agency, which licenses drugs in the U.K., recommended the vaccine could be used after it reviewed the results of clinical trials that showed the vaccine was 95% effective overall — and that it also offered significant protection for older people, among those most at risk of dying from the disease. But the vaccine remains experimental while final testing is done.

“Help is on its way,” British

Read More

COVID-19: Approval of Pfizer vaccine is a historic moment for the UK | Science & Tech News, Reports

This is an historic moment. The beginning of the end of the pandemic. And it starts here in the UK, the first country to licence a COVID-19 vaccine.

The Pfizer/BioNTech jab was shown in clinical trials to prevent 95% of COVID cases. And it works just as well in the elderly, who are most at risk of serious illness from the virus.

With at least 59,000 deaths in the UK, 1.5 million worldwide, never has a vaccine been in greater need.

Live updates on coronavirus from UK and around world

The UK medical regulator has been reviewing data on safety and effectiveness as it came in from clinical trials in recent weeks, so it was able to give it the green light just a week after the companies formally applied for emergency use authorisation.

The first of 40 million doses – enough for 20 million people – will be shipped

Read More

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

Anixa to Host a Conference Call Thursday, December 3, 2020, 1:15 p.m. PT to Discuss Program

SAN JOSE, Calif., Dec. 1, 2020 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that it has entered into a license agreement with Cleveland Clinic for exclusive, world-wide rights to an innovative ovarian cancer vaccine technology. 

Anixa Biosciences, Inc. (PRNewsfoto/Anixa Biosciences, Inc.)

Cleveland Clinic immunologist Dr. Vincent Tuohy has been working on a method to vaccinate women against ovarian cancer and other gynecological malignancies.  This development-stage vaccine targets the extracellular domain of anti-mullerian hormone receptor 2 (AMHR2-ED), that appears in many types of ovarian cancer.  AMHR2-ED is one of several proteins identified by Dr. Tuohy as “retired” proteins.  While these proteins are necessary during the early stages of life, they are “retired” as a person ages, and are no longer expressed, or made at

Read More

Americans have ‘social responsibility’ to get vaccine, Trump advisor says

  • Operation Warp Speed chief advisor Moncef Slaoui said in an interview with The Washington Post on Tuesday that Americans have a “social responsibility” to get vaccinated against the coronavirus.
  • “There is a social responsibility here for everybody to really think hard before deciding not to take the vaccine,” Slaoui said. 
  • Many Americans appear skeptical of a COVID-19 vaccine: One-third said they would not agree to taking a vaccine if it was available, according to a September survey.
  • Pfizer and Moderna have each filed with the Food and Drug Administration for emergency authorized use of their vaccines.
  • Pfizer said its vaccine was 95% effective at preventing COVID-19 in late-stage trials, while Moderna said its was 94.1% effective.
  • Visit Business Insider’s homepage for more stories.

Moncef Slaoui, the chief science advisor to President Donald Trump’s Operation Warp Speed, said Americans have a “social responsibility” in taking the vaccine. Vaccines for existing diseases

Read More